OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
89 hedge funds and large institutions have $189M invested in OncoMed Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
34% more capital invested
Capital invested by funds: $141M → $189M (+$47.4M)
6% more funds holding
Funds holding: 84 → 89 (+5)
Holders
89
Holding in Top 10
3
Calls
$1.84M
Puts
$1.18M
Top Buyers
| 1 | +$12.4M | |
| 2 | +$9.35M | |
| 3 | +$8M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$5.4M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$5.02M |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$308K | |
| 3 | -$229K | |
| 4 |
Barclays
London,
United Kingdom
|
-$198K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$188K |